About
Diabetes & Related
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
118
By Phase
PHASE1/PHASE2: 1NA: 3
By Status
COMPLETED: 3RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06556745Lead Sponsor
Pharmacokinetics of Butyrate Tablet BKR-017
N/ARecruiting
10 participants
Started: Jul 16, 2025 · Completed: Dec 30, 2025
NCT03999853Collaborator
Butyrate Adjuvant Therapy for Type 1 Diabetes
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
NCT04673656Lead Sponsor
Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes Patients
NACompleted
60 participants
Started: Apr 18, 2021 · Completed: Feb 7, 2023
NCT04279444Lead Sponsor
Effects of BKR-017 on Insulin Resistance in Type 2 Diabetes Patients
NACompleted
14 participants
Started: Jun 16, 2020 · Completed: Nov 15, 2020
NCT03382015Lead Sponsor
Effect of BKR-013 on Average Daily Glucose Levels
NACompleted
14 participants
Started: Jan 9, 2018 · Completed: Jun 30, 2018
Locations (1)
Headquarters
Raleigh, NC, United States
Map
Loading map...